Records containing: Hypertension

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2013-11-26
ClinicalTrials.gov study NCT00000513
CLINICAL_TRIALS study record update · 2013-11-19
A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5 mg in Comparison With Losartan 50 mg Plus Hydrochlorothiazide 12.5 mg in Taiwanese Patients With Mild to Moderate Hypertension
CLINICAL_TRIALS study record update · 2013-11-18
Effects of Tetrahydrobiopterin on Blood Pressure
CLINICAL_TRIALS study record update · 2013-11-18
A Randomized, Double Blind, Active Comparator, Parallel-group Study to Determine Whether the Combination of Valsartan and Aliskiren Provides Cardioprotection in African American Patients With Hypertension and Elements of the Metabolic Syndrome
CLINICAL_TRIALS study record update · 2013-11-15
Evaluation of Exercise Benefits to Promote Health Aging Among Chronically Ill Geriatrics in a Community.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2013-11-14
A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of Telmisartan and S-Amlodipine(TELMINUVO TAB.) Versus S-Amlodipine Monotherapy in Patients With Stage 2 Hypertension
CLINICAL_TRIALS study record update · 2013-11-13
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy VIVALDI-Study
CLINICAL_TRIALS study record update · 2013-11-13
Practice-based Trial of Blood Pressure Control in African Americans
CLINICAL_TRIALS study record update · 2013-11-13
An Open-label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 80 mg + Hydrochlorothiazide 25 mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension.
CLINICAL_TRIALS study record update · 2013-11-11
Effect of a Novel Behavioral Intervention on Blood Pressure Control in Hypertension Patients
CLINICAL_TRIALS study record update · 2013-11-11
An Open-label Study to Evaluate the Trough and Peak Effect of Once Daily Micardis Plus (Telmisartan 80mg / Hydrochlorothiazide 12.5 mg) by 24 ABPM in Patients With Mild to Moderate Essential Hypertension
CLINICAL_TRIALS study record update · 2013-11-08
The Vascular Effects of Carvedilol Controlle Release (CR) + Lisinopril Versus Lisinopril + Hydrochlorothiazide (HCTZ) in Abdominally Obese Hypertensive Patients
CLINICAL_TRIALS study record update · 2013-11-08
Prospective, Randomized, Open-label, Blinded Endpoint, Forced Titration Study to Compare Telmisartan Combined With HCTZ (80mg/12.5mg), to Valsartan Combined With HCTZ (160mg/12.5mg), for the Control of Mild-to-moderate Hypertension in Obese Patients With Type 2 Diabetes Mellitus Using ABPM.
CLINICAL_TRIALS study record update · 2013-11-08
TOP -Study Telmisartan - Therapy of Hypertension and Life-style Changes in Cardiovascular Risk Patients
CLINICAL_TRIALS study record update · 2013-11-08
A Prospective, Randomized, Double-blind, Double-dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes
CLINICAL_TRIALS study record update · 2013-11-08
A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
CLINICAL_TRIALS study record update · 2013-11-05
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients in an Urban Emergency Department: Is a Program Focused on Early Detection and Blood Pressure Control Clinically and Cost Effective?
CLINICAL_TRIALS study record update · 2013-11-05
A Randomized, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 40 mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 40 mg
CLINICAL_TRIALS study record update · 2013-11-05
Renal Denervation in Patients With Refractory Hypertension
CLINICAL_TRIALS study record update · 2013-11-05
Renal Denervation in Patients With Refractory Hypertension
CLINICAL_TRIALS study record update · 2013-11-05
A Randomised, Double-blind, Double-dummy, Placebo-controlled, Forced-titration, Comparison of MICARDIS® HCT (Telmisartan 80 mg / Hydrochlorothiazide 25 mg) Versus DIOVAN® HCT (Valsartan 160 mg / Hydrochlorothiazide 25 mg) Using Seated Trough Cuff Blood Pressure in Patients With Stage 1 and Stage 2 Hypertension
CLINICAL_TRIALS study record update · 2013-11-04
Fat Gain and Cardiovascular Disease Mechanisms
CLINICAL_TRIALS study record update · 2013-11-01
A Prospective, Randomized, Double-Blind, Forced Titration Trial to Compare the Efficacy of MICARDIS® (Telmisartan 80 mg p.o. Once Daily) and Diovan® (Valsartan 160 mg p.o. Once Daily) Using Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Hypertension After Missing One Dose
CLINICAL_TRIALS study record update · 2013-11-01
A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-label, Blinded End-point Evaluation. (ATHOS Study)
CLINICAL_TRIALS study record update · 2013-11-01
Pilot Study: Inflammation and Coronary Artery Disease. Role of AT1 Receptor Antagonism